{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:17:27Z","timestamp":1792145847416,"version":"4.4.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Herein, Imiquimod (IMQ) was incorporated in nanotransethosomes (nTES) to develop the IMQ-nTES nano-drug delivery system. IMQ-nTES was optimized using 2<jats:sup>3<\/jats:sup> factorial design. The optimized formulation was expressed with a particle size of 192.4\u2009\u00b1\u20091.60\u00a0nm, Poly-dispersibility of 0.115\u2009\u00b1\u20090.008, and IMQ percent entrapment efficiency of 91.05\u2009\u00b1\u20093.22%. Smooth and round morphology of IMQ-nTES vesicles was confirmed by TEM micrographs. Moreover, FTIR results have shown drug-excipient compatibility. The IMQ-nTES was laden inside the low molecular weight chitosan gel, which exhibited easy application, spreadability and no irritation to the applied skin. The release pattern has clearly exhibited improved dissolution properties of IMQ with the provision of the sustain release pattern. Higher IMQ content was deposited in deeper epidermis and dermis with IMQ-nTES gel, in contrast to ALDARA. In vivo, comparative toxicity study on BALB\/c mice has shown significantly reduced (p\u2009&lt;\u20090.001) psoriatic area severity index (PASI) score and less increment in ear thickness. Epidermal hyperplasia was an obvious finding with ALDARA which was, providentially, minimal in IMQ-nTES gel-treated skin. FTIR analysis of skin tissue has shown an enhancement of lipid and protein content in the ALDARA group, however, in the IMQ-nTES group no such change was observed. With ALDARA application, CD4<jats:sup>+<\/jats:sup> T-cells and constitutive NF-\u03ba\u03b2 expression were significantly elevated, in comparison to the IMQ-nTES gel treated group. Moreover, the adequate expression of IFN-\u03b3 and cytotoxic CD8<jats:sup>+<\/jats:sup> T-cells were suggesting the preserved IMQ efficacy with IMQ-nTES gel. Quantification of cutaneous as well as systemic inflammatory markers has also suggested the reduced psoriatic potential of IMQ-nTES gel. In essence, IMQ-nTES gel can be a suitable alternative to ALDARA owing to its better safety profile.<\/jats:p>","DOI":"10.1038\/s41598-022-18671-1","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T20:05:39Z","timestamp":1661025939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB\/c mice"],"prefix":"10.1038","volume":"12","author":[{"given":"Humzah","family":"Jamshaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhar ud","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimoona","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Mukhtiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Gon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tofeeq","family":"Ur-Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul Majid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,20]]},"reference":[{"key":"18671_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/120347540400800504","volume":"8","author":"AK Gupta","year":"2004","unstructured":"Gupta, A. K., Cherman, A. M. & Tyring, S. K. Viral and nonviral uses of imiquimod: a review. J. Cutan. Med. Surg. 8, 338\u2013352 (2004).","journal-title":"J. Cutan. Med. Surg."},{"key":"18671_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/jdv.13648","volume":"30","author":"K Peris","year":"2016","unstructured":"Peris, K. et al. Italian expert consensus for the management of actinic keratosis in immunocompetent patients. J. Eur. Acad. Dermatol. Venereol. 30, 1077\u20131084 (2016).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"18671_CR3","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/ijd.13235","volume":"55","author":"E Hanna","year":"2016","unstructured":"Hanna, E., Abadi, R. & Abbas, O. Imiquimod in dermatology: An overview. Int. J. Dermatol. 55, 831\u2013844 (2016).","journal-title":"Int. J. Dermatol."},{"key":"18671_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jdermsci.2017.06.012","volume":"87","author":"PA Lopez","year":"2017","unstructured":"Lopez, P. A. et al. Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection. J. Dermatol. Sci. 87, 252\u2013259 (2017).","journal-title":"J. Dermatol. Sci."},{"key":"18671_CR5","first-page":"1488","volume":"867","author":"CA Del Guzzo","year":"2021","unstructured":"Del Guzzo, C. A. et al. Antibiotics and imiquimod for CTCL in veterans: A patient population with agent orange exposure. Oncologist 867, 1488 (2021).","journal-title":"Oncologist"},{"key":"18671_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ad.2016.03.004","volume":"107","author":"I El\u00edas","year":"2016","unstructured":"El\u00edas, I. et al. Cost-effectiveness and cost-utility analysis of ingenol mebutate versus diclofenac 3% and imiquimod 5% in the treatment of actinic keratosis in Spain. Actas Dermosifiliogr. 107, 498\u2013508 (2016).","journal-title":"Actas Dermosifiliogr."},{"key":"18671_CR7","doi-asserted-by":"crossref","unstructured":"Stein P, et al. (2014) Efficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulation. PLoS One 9, e102664-e.","DOI":"10.1371\/journal.pone.0102664"},{"key":"18671_CR8","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S.-C. NF-\u03baB signaling in inflammation. Signal Transduct. Target. Ther. 2, 1\u20139 (2017).","journal-title":"Signal Transduct. Target. Ther."},{"key":"18671_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4103\/0253-7613.161249","volume":"47","author":"AK Bubna","year":"2015","unstructured":"Bubna, A. K. Imiquimod-Its role in the treatment of cutaneous malignancies. Indian J. Pharmacol. 47, 354 (2015).","journal-title":"Indian J. Pharmacol."},{"key":"18671_CR10","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1038\/jid.2009.151","volume":"129","author":"SJ Huang","year":"2009","unstructured":"Huang, S. J. et al. Imiquimod enhances IFN-\u03b3 production and effector function of T cells infiltrating human squamous cell carcinomas of the skin. J. Invest. Dermatol. 129, 2676\u20132685 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"18671_CR11","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Van der Fits","year":"2009","unstructured":"Van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J. Immunol. 182, 5836\u20135845 (2009).","journal-title":"J. Immunol."},{"key":"18671_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1440-0960.2004.00030.x","volume":"45","author":"JK Wu","year":"2004","unstructured":"Wu, J. K., Siller, G. & Strutton, G. Psoriasis induced by topical imiquimod. Australas. J. Dermatol. 45, 47\u201350 (2004).","journal-title":"Australas. J. Dermatol."},{"key":"18671_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2010.02.064","volume":"64","author":"B Machler","year":"2011","unstructured":"Machler, B., Mark, N., Patel, U. & Levine, V. Imiquimod induced psoriasis: A case report, review of the literature, and pathophysiologic mechanism: P3313. J. Am. Acad. Dermatol. 64, 1 (2011).","journal-title":"J. Am. Acad. Dermatol."},{"key":"18671_CR14","doi-asserted-by":"publisher","first-page":"5625","DOI":"10.2147\/IJN.S170832","volume":"13","author":"L Sun","year":"2018","unstructured":"Sun, L. et al. Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles. Int. J. Nanomed. 13, 5625\u20135635 (2018).","journal-title":"Int. J. Nanomed."},{"key":"18671_CR15","doi-asserted-by":"crossref","unstructured":"Sun J, Zhao Y, Hu J. (2013) Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice. PLoS One 8, e67078-e.","DOI":"10.1371\/journal.pone.0067078"},{"key":"18671_CR16","doi-asserted-by":"crossref","unstructured":"Kj\u00e6r TN, Thorsen K, Jessen N, Stenderup K, Pedersen SB. (2015) Resveratrol ameliorates imiquimod-induced psoriasis-like skin inflammation in mice. PLoS One 10, e0126599-e.","DOI":"10.1371\/journal.pone.0126599"},{"key":"18671_CR17","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/eji.201343801","volume":"43","author":"B Flutter","year":"2013","unstructured":"Flutter, B. & Nestle, F. O. TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur. J. Immunol. 43, 3138\u20133146 (2013).","journal-title":"Eur. J. Immunol."},{"key":"18671_CR18","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3390\/ijms19071822","volume":"19","author":"X Pang","year":"2018","unstructured":"Pang, X. et al. Decryption of active constituents and action mechanism of the traditional uighur prescription (BXXTR) alleviating IMQ-induced psoriasis-like skin inflammation in BALB\/c mice. Int. J. Mol. Sci. 19, 1822 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"18671_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","volume":"69","author":"AM Goldminz","year":"2013","unstructured":"Goldminz, A. M., Au, S. C., Kim, N., Gottlieb, A. B. & Lizzul, P. F. NF-\u03baB: an essential transcription factor in psoriasis. J. Dermatol. Sci. 69, 89\u201394 (2013).","journal-title":"J. Dermatol. Sci."},{"key":"18671_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms2566","volume":"4","author":"A Walter","year":"2013","unstructured":"Walter, A. et al. Aldara activates TLR7-independent immune defence. Nat. Commun. 4, 1\u201313 (2013).","journal-title":"Nat. Commun."},{"key":"18671_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.it.2012.03.001","volume":"33","author":"R Hanamsagar","year":"2012","unstructured":"Hanamsagar, R., Hanke, M. L. & Kielian, T. Toll-like receptor (TLR) and inflammasome actions in the central nervous system. Trends Immunol. 33, 333\u2013342 (2012).","journal-title":"Trends Immunol."},{"key":"18671_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ijpharm.2016.07.043","volume":"511","author":"I Tel\u00f2","year":"2016","unstructured":"Tel\u00f2, I., Pescina, S., Padula, C., Santi, P. & Nicoli, S. Mechanisms of imiquimod skin penetration. Int. J. Pharm. 511, 516\u2013523 (2016).","journal-title":"Int. J. Pharm."},{"key":"18671_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-00853-0","volume":"19","author":"H Jamshaid","year":"2021","unstructured":"Jamshaid, H. & ud Din F, Khan GM.,. Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight. J. Nanobiotechnol. 19, 1\u201351 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"18671_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"WH De Jong","year":"2008","unstructured":"De Jong, W. H. & Borm, P. J. A. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed. 3, 133\u2013149 (2008).","journal-title":"Int. J. Nanomed."},{"key":"18671_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jddst.2019.02.026","volume":"51","author":"ud Din F, Zeb A, Shah KU.","year":"2019","unstructured":"ud Din F, Zeb A, Shah KU.,. Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product. J. Drug Deliv. Sci. Technol. 51, 583\u2013590 (2019).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"18671_CR26","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/jphp.12802","volume":"69","author":"FS Tonin","year":"2017","unstructured":"Tonin, F. S. et al. Efficacy and safety of amphotericin B formulations: A network meta-analysis and a multicriteria decision analysis. J. Pharm. Pharmacol. 69, 1672\u20131683 (2017).","journal-title":"J. Pharm. Pharmacol."},{"key":"18671_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1517\/14656566.4.8.1277","volume":"4","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht, R., Natarajan-Am\u00e9, S., Nivoix, Y. & Letscher-Bru, V. The lipid formulations of amphotericin B. Expert Opin. Pharmacother. 4, 1277\u20131287 (2002).","journal-title":"Expert Opin. Pharmacother."},{"key":"18671_CR28","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.2147\/IJN.S299443","volume":"16","author":"G Yu","year":"2021","unstructured":"Yu, G. et al. Preparation, pharmacokinetics, and antitumor potential of miltefosine-loaded nanostructured lipid carriers. Int. J. Nanomed. 16, 3255\u20133273 (2021).","journal-title":"Int. J. Nanomed."},{"key":"18671_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40942-019-0186-7","volume":"5","author":"MB Abud","year":"2019","unstructured":"Abud, M. B. et al. In vivo and in vitro toxicity evaluation of liposome-encapsulated sirolimus. Int. J. Retin. Vitr. 5, 1\u201310 (2019).","journal-title":"Int. J. Retin. Vitr."},{"key":"18671_CR30","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.2174\/1389450115666140804124808","volume":"16","author":"J Wolfram","year":"2022","unstructured":"Wolfram, J. et al. Safety of nanoparticles in medicine. Curr. Drug Targets 16, 1671\u20131681 (2022).","journal-title":"Curr. Drug Targets"},{"key":"18671_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-021-02166-9","volume":"23","author":"MW Akram","year":"2022","unstructured":"Akram, M. W., Jamshaid, H., Rehman, F. U., Zaeem, M. & Zeb, A. Transfersomes: a Revolutionary nanosystem for efficient transdermal drug delivery. AAPS PharmSciTech 23, 1\u201318 (2022).","journal-title":"AAPS PharmSciTech"},{"key":"18671_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/DDDT.S158018","volume":"12","author":"IM Abdulbaqi","year":"2018","unstructured":"Abdulbaqi, I. M., Darwis, Y., Abou Assi, R. & Khan, N. A. K. Transethosomal gels as carriers for the transdermal delivery of colchicine: Statistical optimization, characterization, and ex vivo evaluation. Drug Des. Devel. Ther. 12, 795\u2013813 (2018).","journal-title":"Drug Des. Devel. Ther."},{"key":"18671_CR33","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2147\/IJN.S86186","volume":"10","author":"A Ascenso","year":"2015","unstructured":"Ascenso, A. et al. Development, characterization, and skin delivery studies of related ultradeformable vesicles: Transfersomes, ethosomes, and transethosomes. Int. J. Nanomed. 10, 5837\u20135851 (2015).","journal-title":"Int. J. Nanomed."},{"key":"18671_CR34","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/polym13040551","volume":"13","author":"SG Jin","year":"2021","unstructured":"Jin, S. G. & Choi, H.-G. Particle and gel characterization of irinotecan-loaded double-reverse thermosensitive hydrogel. Polymers 13, 551 (2021).","journal-title":"Polymers"},{"key":"18671_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120109","volume":"593","author":"AS Khan","year":"2021","unstructured":"Khan, A. S. et al. Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of cutaneous leishmaniasis. Int. J. Pharm. 593, 120109 (2021).","journal-title":"Int. J. Pharm."},{"key":"18671_CR36","doi-asserted-by":"publisher","first-page":"43687","DOI":"10.1039\/C5RA05656J","volume":"5","author":"ud Din F,","year":"2015","unstructured":"ud Din F, et al. Development of a novel solid lipid nanoparticles-loaded dual-reverse thermosensitive nanomicelle for intramuscular administration with sustained release and reduced toxicity. RSC Adv. 5, 43687\u201343694 (2015).","journal-title":"RSC Adv."},{"key":"18671_CR37","first-page":"129","volume":"9","author":"WM Ibrahim","year":"2014","unstructured":"Ibrahim, W. M., AlOmrani, A. H. & Yassin, A. E. B. Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability. Int. J. Nanomedicine 9, 129\u2013144 (2014).","journal-title":"Int. J. Nanomedicine"},{"key":"18671_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120871","volume":"606","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. Topotecan-loaded thermosensitive nanocargo for tumor therapy: In vitro and in vivo analyses. Int. J. Pharm. 606, 120871 (2021).","journal-title":"Int. J. Pharm."},{"key":"18671_CR39","first-page":"16","volume":"35","author":"S Jain","year":"2015","unstructured":"Jain, S., Diwan, A. & Sardana, S. Development and validation of UV spectroscopy and RP-HPLC methods for estimation of imiquimod. Int. J. Pharm. Sci 35, 16\u201321 (2015).","journal-title":"Int. J. Pharm. Sci"},{"key":"18671_CR40","first-page":"1","volume":"58","author":"SA El-Gizawy","year":"2020","unstructured":"El-Gizawy, S. A., Nouh, A., Saber, S. & Kira, A. Y. Deferoxamine-loaded transfersomes accelerates healing of pressure ulcers in streptozotocin-induced diabetic rats. J. Drug. Deliv. Sci. Technol. 58, 1\u201315 (2020).","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"18671_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10837450.2017.1419256","volume":"24","author":"Fakhar ud D, Khan GM.","year":"2019","unstructured":"Fakhar ud D, Khan GM.,. Development and characterisation of levosulpiride-loaded suppositories with improved bioavailability in vivo. Pharm. Dev. Technol. 24, 63\u201369 (2019).","journal-title":"Pharm. Dev. Technol."},{"key":"18671_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2217\/nnm-2019-0320","volume":"15","author":"S Rabia","year":"2020","unstructured":"Rabia, S. et al. Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: Passive targeting via topical route. Nanomedicine 15, 183\u2013203 (2020).","journal-title":"Nanomedicine"},{"key":"18671_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102972","volume":"67","author":"A Mushtaq","year":"2022","unstructured":"Mushtaq, A. et al. Fluconazole-loaded thermosensitive system: In vitro release, pharmacokinetics and safety study. J. Drug Deliv. Sci. Technol. 67, 102972 (2022).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"18671_CR44","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1080\/10717544.2018.1494222","volume":"25","author":"MJ Dar","year":"2018","unstructured":"Dar, M. J., Din, F. U. & Khan, G. M. Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell. Drug Deliv. 25, 1595\u20131606 (2018).","journal-title":"Drug Deliv."},{"key":"18671_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101996","volume":"60","author":"MW Salim","year":"2020","unstructured":"Salim, M. W., Shabbir, K., Yousaf, A. M., Choi, H.-G. & Khan, G. M. Preparation, in-vitro and in-vivo evaluation of Rifampicin and Vancomycin Co-loaded transfersomal gel for the treatment of cutaneous leishmaniasis. J. Drug. Deliv. Sci. Technol. 60, 101996 (2020).","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"18671_CR46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/pharmaceutics12060523","volume":"12","author":"D Van Staden","year":"2020","unstructured":"Van Staden, D., Du Plessis, J. & Viljoen, J. Development of a self-emulsifying drug delivery system for optimized topical delivery of clofazimine. Pharmaceutics 12, 523\u2013547 (2020).","journal-title":"Pharmaceutics"},{"key":"18671_CR47","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejps.2016.12.026","volume":"99","author":"ZX Chen","year":"2017","unstructured":"Chen, Z. X. et al. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. Eur. J. Pharm. Sci. 99, 240\u2013245 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"key":"18671_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejps.2020.105256","volume":"145","author":"MJ Dar","year":"2020","unstructured":"Dar, M. J., Khalid, S., Varikuti, S., Satoskar, A. R. & Khan, G. M. Nano-elastic liposomes as multidrug carrier of sodium stibogluconate and ketoconazole: A potential new approach for the topical treatment of cutaneous Leishmaniasis. Eur. J. Pharm. Sci. 145, 1\u201311 (2020).","journal-title":"Eur. J. Pharm. Sci."},{"key":"18671_CR49","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2217\/nnm-2020-0316","volume":"16","author":"E Sana","year":"2021","unstructured":"Sana, E. et al. Topical delivery of curcumin-loaded transfersomes gel ameliorated rheumatoid arthritis by inhibiting NF-\u03ba\u03b2 pathway. Nanomedicine 16, 819\u2013837 (2021).","journal-title":"Nanomedicine"},{"key":"18671_CR50","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/bmc.1075","volume":"22","author":"DD Paula","year":"2008","unstructured":"Paula, D. D., Martins, C. A. & Bentley, M. V. L. B. Development and validation of HPLC method for imiquimod determination in skin penetration studies. Biomed. Chromatogr. 22, 1416\u20131423 (2008).","journal-title":"Biomed. Chromatogr."},{"key":"18671_CR51","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","volume":"12","author":"M Jabeen","year":"2020","unstructured":"Jabeen, M. et al. Advanced characterization of imiquimod-induced psoriasis-like mouse model. Pharmaceutics 12, 789\u2013807 (2020).","journal-title":"Pharmaceutics"},{"key":"18671_CR52","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1097\/j.pain.0000000000000674","volume":"157","author":"K Sakai","year":"2016","unstructured":"Sakai, K. et al. Mouse model of imiquimod-induced psoriatic itch. Pain 157, 2536 (2016).","journal-title":"Pain"},{"key":"18671_CR53","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/exd.13534","volume":"27","author":"SY Turin","year":"2018","unstructured":"Turin, S. Y. et al. Digital analysis yields more reliable and accurate measures of dermal and epidermal thickness in histologically processed specimens compared to traditional methods. Exp. Dermatol. 27, 687\u2013690 (2018).","journal-title":"Exp. Dermatol."},{"key":"18671_CR54","first-page":"1","volume":"20","author":"F\u0102L\u0102Ma\u015e A, C\u00ceNt\u0102-P\u00ceNzaru S, Dehelea","year":"2010","unstructured":"F\u0102L\u0102Ma\u015e A, C\u00ceNt\u0102-P\u00ceNzaru S, Dehelean C, Krafft CH, Popp J.,. Raman and FT-IR imaging of in vivo damaged tissue induced by 7, 12-dimethylbenzanthracene (DMBA) in mouse models. Rom. J. Biophys 20, 1\u201311 (2010).","journal-title":"Rom. J. Biophys"},{"key":"18671_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7692024","volume":"2016","author":"M Diani","year":"2016","unstructured":"Diani, M., Altomare, G. & Reali, E. T helper cell subsets in clinical manifestations of psoriasis. J. Immunol. Res. 2016, 1\u20137 (2016).","journal-title":"J. Immunol. Res."},{"key":"18671_CR56","first-page":"6","volume":"4","author":"R Guo","year":"2019","unstructured":"Guo, R. et al. Lymphocyte mass cytometry identifies a CD3\u2013CD4+ cell subset with a potential role in psoriasis. JCI Insight 4, 6 (2019).","journal-title":"JCI Insight"},{"key":"18671_CR57","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1232219","volume":"5","author":"C Hotz","year":"2016","unstructured":"Hotz, C. et al. Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses. Oncoimmunology 5, e1232219 (2016).","journal-title":"Oncoimmunology"},{"key":"18671_CR58","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1007\/s11033-021-06313-0","volume":"48","author":"Z Ali","year":"2021","unstructured":"Ali, Z. et al. Association of cell free mitochondrial DNA and caspase-1 expression with disease severity and ARTs efficacy in HIV infection. Mol. Biol. Rep. 48, 3327\u20133336 (2021).","journal-title":"Mol. Biol. Rep."},{"key":"18671_CR59","doi-asserted-by":"publisher","first-page":"e663","DOI":"10.3389\/fphar.2019.00663","volume":"10","author":"FA Shah","year":"2019","unstructured":"Shah, F. A. et al. Polydatin attenuates neuronal loss via reducing neuroinflammation and oxidative stress in rat MCAO models. Front. Pharmacol. 10, e663\u2013e733 (2019).","journal-title":"Front. Pharmacol."},{"key":"18671_CR60","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/1346-8138.14139","volume":"45","author":"E Ogawa","year":"2020","unstructured":"Ogawa, E., Sato, Y., Minagawa, A. & Okuyama, R. Pathogenesis of psoriasis and development of treatment. J. Dermatol. 45, 264\u2013272 (2020).","journal-title":"J. Dermatol."},{"key":"18671_CR61","doi-asserted-by":"crossref","unstructured":"Zhou, W., et al. Luteolin attenuates imiquimod\u2013induced psoriasis-like skin lesions in BALB\/c mice via suppression of inflammation response. Biomed. Pharmacother. 131, 110696 (2020).","DOI":"10.1016\/j.biopha.2020.110696"},{"key":"18671_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","volume":"26","author":"K Reich","year":"2012","unstructured":"Reich, K. The concept of psoriasis as a systemic inflammation: Implications for disease management. J. Eur. Acad. Dermatol. Venereol. 26, 3\u201311 (2012).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"18671_CR63","doi-asserted-by":"crossref","unstructured":"Agarwal, N. R., et al. Investigation of psoriasis skin tissue by label-free multi-modal imaging: a case study on a phototherapy-treated patient. Psoriasis Targets Ther. 9, 43\u201357 (2019).","DOI":"10.2147\/PTT.S200366"},{"key":"18671_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11671-017-2249-8","volume":"12","author":"M Mir","year":"2017","unstructured":"Mir, M. et al. Nanotechnology: from in vivo imaging system to controlled drug delivery. Nanoscale Res. Lett. 12, 1\u201316 (2017).","journal-title":"Nanoscale Res. Lett."},{"key":"18671_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111209","volume":"194","author":"I Rana","year":"2020","unstructured":"Rana, I. et al. Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model. Colloids Surf., B 194, 111209 (2020).","journal-title":"Colloids Surf., B"},{"key":"18671_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103581","volume":"74","author":"M Bibi","year":"2022","unstructured":"Bibi, M. et al. Cilostazol-loaded solid lipid nanoparticles: Bioavailability and safety evaluation in an animal model. J. Drug Deliv. Sci. Technol. 74, 103581 (2022).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"18671_CR67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.actbio.2017.03.007","volume":"54","author":"ud Din F,","year":"2017","unstructured":"ud Din F, et al. Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration. Acta Biomater. 54, 239\u2013248 (2017).","journal-title":"Acta Biomater."},{"key":"18671_CR68","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.colsurfb.2011.12.004","volume":"92","author":"CK Song","year":"2012","unstructured":"Song, C. K. et al. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro\/in vivo evaluation. Colloids Surf. B 92, 299\u2013304 (2012).","journal-title":"Colloids Surf. B"},{"key":"18671_CR69","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/08982104.2016.1174943","volume":"27","author":"N Singh","year":"2017","unstructured":"Singh, N. et al. Oral delivery of allopurinol niosomes in treatment of gout in animal model. J. Liposome Res. 27, 130\u2013138 (2017).","journal-title":"J. Liposome Res."},{"key":"18671_CR70","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/21691401.2018.1469025","volume":"46","author":"T Moolakkadath","year":"2018","unstructured":"Moolakkadath, T. et al. Development of transethosomes formulation for dermal fisetin delivery: Box-Behnken design, optimization, in vitro skin penetration, vesicles\u2013skin interaction and dermatokinetic studies. Artif. Cells Nanomed. Biotechnol. 46, 755\u2013765 (2018).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"18671_CR71","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/pharmaceutics12090855","volume":"12","author":"SAT Opatha","year":"2020","unstructured":"Opatha, S. A. T., Titapiwatanakun, V. & Chutoprapat, R. Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics 12, 855\u2013878 (2020).","journal-title":"Pharmaceutics"},{"key":"18671_CR72","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/B978-0-12-814421-3.00011-7","volume-title":"Dosage form design parameters","author":"B Gorain","year":"2018","unstructured":"Gorain, B. et al. Drug\u2013excipient interaction and incompatibilities. In Dosage form design parameters 363\u2013402 (Elsevier, 2018)."},{"key":"18671_CR73","first-page":"621","volume":"5","author":"B Sahana","year":"2010","unstructured":"Sahana, B., Santra, K., Basu, S. & Mukherjee, B. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: A physicochemical and in-vitro evaluation. Int. J. Nanomed. 5, 621 (2010).","journal-title":"Int. J. Nanomed."},{"key":"18671_CR74","doi-asserted-by":"crossref","unstructured":"Sonia, T., & Sharma, C. P. Chitosan and its derivatives for drug delivery perspective. in Chitosan for biomaterials 2011, Springer: Berlin, Heidelberg. p. 23\u201353.","DOI":"10.1007\/12_2011_117"},{"key":"18671_CR75","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/10837459908984222","volume":"4","author":"JL Chollet","year":"1999","unstructured":"Chollet, J. L. et al. Development of a topically active imiquimod formulation. Pharm. Dev. Technol. 4, 35\u201343 (1999).","journal-title":"Pharm. Dev. Technol."},{"key":"18671_CR76","doi-asserted-by":"publisher","first-page":"9701","DOI":"10.1021\/jm501000a","volume":"57","author":"PS Charifson","year":"2014","unstructured":"Charifson, P. S. & Walters, W. P. Acidic and basic drugs in medicinal chemistry: A perspective. J. Med. Chem. 57, 9701\u20139717 (2014).","journal-title":"J. Med. Chem."},{"key":"18671_CR77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejpb.2015.04.019","volume":"94","author":"ud Din F,","year":"2015","unstructured":"ud Din F, et al. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect. Eur. J. Pharm. Biopharm. 94, 64\u201372 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"18671_CR78","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40005-018-00418-8","volume":"49","author":"A Zeb","year":"2019","unstructured":"Zeb, A. et al. Potential of nanoparticulate carriers for improved drug delivery via skin. J. Pharm. Investig. 49, 485\u2013517 (2019).","journal-title":"J. Pharm. Investig."},{"key":"18671_CR79","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/03639045.2021.1890768","volume":"47","author":"S Batool","year":"2021","unstructured":"Batool, S. et al. Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: In vitro and in vivo analyses. Drug Dev. Ind. Pharm. 47, 440\u2013453 (2021).","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"18671_CR80","first-page":"160","volume":"37","author":"Khaleeq","year":"2020","unstructured":"Khaleeq, et al. Development of levosulpiride-loaded solid lipid nanoparticles and their in vitro and in vivo comparison with commercial product. J. Micro Encapsul. 37(2), 160\u2013169 (2020).","journal-title":"J. Micro Encapsul."},{"key":"18671_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11514","volume":"7","author":"N Collins","year":"2016","unstructured":"Collins, N. et al. Skin CD4+ memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation. Nat. Commun. 7, 1\u201313 (2016).","journal-title":"Nat. Commun."},{"key":"18671_CR82","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai, T. & Akira, S. Signaling to NF-\u03baB by Toll-like receptors. Trends Mol. Med. 13, 460\u2013469 (2007).","journal-title":"Trends Mol. Med."},{"key":"18671_CR83","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12906-022-03629-7","volume":"22","author":"A Khan","year":"2022","unstructured":"Khan, A. et al. Suppression of NF-\u03baB signaling by ECN in an arthritic model of inflammation. BMC Complement. Med. Ther. 22, 158 (2022).","journal-title":"BMC Complement. Med. Ther."},{"key":"18671_CR84","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1172\/jci.insight.130835","volume":"4","author":"S Lorscheid","year":"2019","unstructured":"Lorscheid, S. et al. Keratinocyte-derived I\u03baB\u03b6 drives psoriasis and associated systemic inflammation. JCI Insight 4, 22 (2019).","journal-title":"JCI Insight"},{"key":"18671_CR85","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.biopha.2018.04.079","volume":"103","author":"MF Dias","year":"2018","unstructured":"Dias, M. F. et al. In vivo evaluation of antitumoral and antiangiogenic effect of imiquimod-loaded polymeric nanoparticles. Biomed. Pharmacother. 103, 1107\u20131114 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"18671_CR86","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","volume":"73","author":"J Baliwag","year":"2015","unstructured":"Baliwag, J., Barnes, D. H. & Johnston, A. Cytokines in psoriasis. Cytokine 73, 342\u2013350 (2015).","journal-title":"Cytokine"},{"key":"18671_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12865-021-00401-3","volume":"22","author":"Q Li","year":"2021","unstructured":"Li, Q., Liu, W., Gao, S., Mao, Y. & Xin, Y. Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist. BMC Immunol. 22, 1\u201311 (2021).","journal-title":"BMC Immunol."},{"key":"18671_CR88","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/jir.2011.0028","volume":"31","author":"LM Pfeffer","year":"2011","unstructured":"Pfeffer, L. M. The role of nuclear factor \u03baB in the interferon response. J. Interferon Cytokine Res. 31, 553\u2013559 (2011).","journal-title":"J. Interferon Cytokine Res."},{"key":"18671_CR89","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.immuni.2013.10.010","volume":"39","author":"V Bronte","year":"2013","unstructured":"Bronte, V. & Pittet, M. J. The spleen in local and systemic regulation of immunity. Immunity 39, 806\u2013818 (2013).","journal-title":"Immunity"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18671-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18671-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18671-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T07:37:58Z","timestamp":1669361878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18671-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18671"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18671-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,20]]},"assertion":[{"value":"13 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14244"}}